New research shows the efficacy and safety of hydroxyurea treatment for sickle cell anemia at four low-income sites in Africa, with no increase in clinically diagnosed infections.

When Isimbi’s son was five months old, she began noticing signs that something was wrong. He cried excessively, developed fevers and blood infections, and often appeared to be in severe pain. Later, ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Researchers have carried out the first single-cell analysis of mitochondrial DNA in a population of brainstem neurons that ...

Certain cells, commonly called excitable cells, are unique because of their ability to generate electrical signals. Although ...

Johns Hopkins researchers have identified a WIF1-expressing basal epithelial cell type concentrated in the prostate's ...

The collaboration is intended to advance GCC2005's global clinical development strategy and enhance the design of a planned ...

Cellex Cell Professionals has surpassed 10,000 autologous manufacturing batches for advanced therapy medicinal products ...

The recurrent head and neck squamous cell carcinoma clinical trial analysis report delivers important insights into ongoing research on 75+ pipeline recurrent head and neck squamous cell carcinoma ...